A Bioavailability Study of SHR1459 on Healthy Chinese Volunteers
Status:
Not yet recruiting
Trial end date:
2020-10-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to evaluate the pharmacokinetics of healthy Chinese
volunteers after oral administration of SHR1459 tablets in new and old formulations.
The secondary objective of the study is to evaluate the safety after single dose of SHR1459
orally in healthy Chinese subjects.